Physician profile
David Selzer
NPI 1194069377
$13,081.41
in general payments reported to CMS, 2019-2025
50 companies · $2,512 in 2025
The $2,512 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $1,116 · 2021: $1,510 · 2022: $2,762 · 2023: $1,952 · 2024: $2,248 · 2025: $2,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,712.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,609.54 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $1,505.26 | 2022-2025 | |
| Glaxosmithkline, LLC. | $1,291.30 | 2019-2024 | Nucala, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,163.59 | 2020-2025 | Jardiance, Tradjenta, Stiolto Respimat |
| Lilly USA, LLC | $967.74 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $860.92 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Amgen INC. | $592.46 | 2019-2025 | Evenity, Prolia, Repatha |
| Abbott Laboratories | $474.05 | 2019-2025 | Cardiomems, Freestyle Libre 3, Freestyle Libre 2 |
| Medtronic, INC. | $294.95 | 2022-2024 | Intellis Adaptivestim, Micra |
| Novartis Pharmaceuticals Corporation | $282.03 | 2022-2025 | |
| Pfizer INC. | $273.26 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $264.91 | 2023-2025 | Gemtesa |
| Edwards Lifesciences Corporation | $230.90 | 2021-2024 | |
| Abbvie INC. | $190.48 | 2021-2025 | Ubrelvy, Qulipta |
| Medtronic Vascular, INC. | $176.25 | 2019 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $161.63 | 2022-2025 | Veltassa |
| Biohaven Pharmaceutical Holding Company Ltd. | $153.93 | 2022 | |
| Astellas Pharma US INC | $140.58 | 2019-2025 | Veozah |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.52 | 2020-2024 | Lifevest |
| Boston Scientific Corporation | $124.46 | 2019-2024 | Watchman, Watchman Flx, Watchman Access System |
| Otsuka America Pharmaceutical, INC. | $107.31 | 2022-2024 | Rexulti, Jynarque |
| Merck Sharp & Dohme LLC | $84.95 | 2023-2025 | Verquvo, Capvaxive, Belsomra |
| Kestra Medical Technology Services, INC. | $73.77 | 2025 | Assure Wcd |
| Amarin Pharma, INC. | $68.12 | 2020-2022 | |
| Exact Sciences Corporation | $66.49 | 2024-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $64.68 | 2021-2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $63.73 | 2020-2025 | Zoryve |
| Lundbeck LLC | $61.17 | 2020 | |
| Shield Therapeutics INC | $54.52 | 2023 | Accrufer |
| Smith+Nephew, INC. | $52.37 | 2024 | Or3o Dual Mobility, Real Intelligence |
| Corcept Therapeutics | $46.49 | 2023-2025 | Korlym |
| Coloplast Corp | $44.44 | 2020 | |
| Biosense Webster, INC. | $44.23 | 2022-2023 | Carto 3 |
| Antares Pharma, INC. | $34.62 | 2024 | Xyosted |
| Nevro Corp. | $29.03 | 2024 | Senza |
| Sunovion Pharmaceuticals INC. | $28.06 | 2022 | |
| Sanofi-Aventis U.S. LLC | $25.59 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.32 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.61 | 2023 | Xifaxan |
| Philips North America LLC | $23.65 | 2024 | (5091) Amb Mon & Diag Und |
| Baxter Healthcare | $22.87 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $21.77 | 2019 | |
| Organogenesis INC. | $19.72 | 2021 | |
| Gilead Sciences, INC. | $18.80 | 2025 | |
| Esperion Therapeutics, INC. | $15.96 | 2024 | Nexletol |
| Ibsa Pharma INC. | $14.78 | 2025 | Tirosint, Licart, Flector |
| Allergan, INC. | $14.09 | 2020 | |
| G Medical Diagnostic Services, INC. | $13.80 | 2024 | Cardiac Monitoring Suite |
| Tactile Systems Technology INC | $13.58 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Selzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.